Home › Bladder Cancer › California › Baldwin Park
Bladder Cancer clinical trials in Baldwin Park, CA
14 studies for Bladder Cancer are looking for participants at sites in and around Baldwin Park (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecruitingPhase 1
- City of Hope National Medical Center, Duarte · 4 mi away
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
- City of Hope - Duarte Cancer Center, Duarte · 4 mi away
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
- City of Hope, Duarte · 4 mi away
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RecruitingPhase 1
- City of Hope National Medical Center, Duarte · 4 mi away
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RecruitingPhase 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RecruitingPhase 1/2
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mi away
- City of Hope Investigational Drug Services (IDS), Duarte · 4 mi away
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- City of Hope Cancer Center-Duarte, Duarte · 4 mi away
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RecruitingPhase 2
- Kaiser Permanente Baldwin Park Medical Center, Baldwin Park
Telehealth Intervention for Ostomy Self-Management
RecruitingPhase 2
- City of hope Medical Center, Duarte · 4 mi away
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
- City of Hope, Duarte · 4 mi away
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Recruiting
- City of Hope Medical Center, Duarte · 4 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Duarte · 4 mi away
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY35 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Dallas, TX27 studies
- Boston, MA26 studies
- Washington, DC26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Philadelphia, PA21 studies
- Seattle, WA21 studies
- Edison, NJ21 studies
Other studies in Baldwin Park
- Breast Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Colorectal Cancer38 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)33 studies
- Prostate Cancer30 studies
- Metastatic Cancer30 studies
- Myelodysplastic Syndromes26 studies
- Ovarian Cancer25 studies
- Lung Cancer24 studies
- Multiple Myeloma23 studies
- Stomach Cancer22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.